MedPath

Radha Pharmaceuticals Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

9

FDA:9

Drug Approvals

Carbidopa and Levodopa

Approval Date
Apr 25, 2025
FDA

Gabapentin

Approval Date
Nov 9, 2023
FDA

Clopidogrel bisulfate

Approval Date
Nov 8, 2023
FDA

Naproxen

Approval Date
Nov 8, 2023
FDA

ATORVASTATIN CALCIUM

Approval Date
Aug 17, 2023
FDA

Bupropion Hydrochloride

Approval Date
Mar 16, 2023
FDA

Bupropion Hydrochloride

Approval Date
Nov 3, 2022
FDA

Fluoxetine

Approval Date
Oct 28, 2022
FDA

Hydralazine Hydrochloride

Approval Date
Mar 12, 2021
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.